{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:18:46Z","timestamp":1780730326924,"version":"3.54.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Multiple myeloma (MM) with secondary amyloidosis (AL) is a rare clonal plasma cell proliferation disease, which causes dysfunction of multiple organs and tissues. We report a case of dysphagia as the first symptom in a patient with MM and secondary AL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The patient was a 73-year-old female, was admitted to our hospital, because of progressive dysphagia for 4 months and limb weakness for 1 month.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The bone marrow smear and pathology diagnosis revealed the presence of MM, while the biceps myopathy diagnosis indicated AL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The VCD regimen consisted of bortezomib at a dosage of 1.9\u2009mg on days 1, 8, 15, and 22, cyclophosphamide 0.4\u2009g on days 1, 8, and 15, and dexamethasone at a dosage of 40\u2009mg on days 1, 8, 15, and 22. The patient simultaneously received comprehensive treatment including anti-infective therapy, enhanced cardiac function, and nutritional support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The M protein in the blood and urine protein were negative, indicating a reduction in bone marrow plasma cells to 2%. Flow cytometric analysis revealed a minimal percentage 0.04%. As a result, complete remission was achieved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>The clinical manifestations of MM exhibit a wide range, with the symptoms of secondary injury causing significant disturbing, while the atypical symptoms of extramedullary manifestations pose challenges in diagnosing the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000038968","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:09:49Z","timestamp":1720796989000},"page":"e38968","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Multiple myeloma with secondary amyloidosis: Dysphagia as the first symptom: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Bing","family":"Xue","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Zibo Central Hospital of Shandong University, Zibo, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Zibo Central Hospital of Shandong University, Zibo, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-8756","authenticated-orcid":false,"given":"Shanshan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Zibo Central Hospital of Shandong University, Zibo, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.","volume":"21","author":"Varettoni","year":"2010","journal-title":"Ann Oncol"},{"key":"R2-20260204","first-page":"9159035","article-title":"Extraosseous multiple myeloma: case report of presentation in the lower extremity soft tissues with literature review.","volume":"2017","author":"Ames","year":"2017","journal-title":"Case Rep Radiol"},{"key":"R3-20260204","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2214\/AJR.10.4384","article-title":"Imaging of extraosseous myeloma: CT, PET\/CT, and MRI features.","volume":"195","author":"Hall","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","article-title":"Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts.","volume":"85","author":"Alexiou","year":"1999","journal-title":"Cancer"},{"key":"R5-20260204","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajg.2020.01.002","article-title":"Multiple myeloma with primary amyloidosis presenting with digestive symptoms: a case report and literature review.","volume":"21","author":"Hu","year":"2020","journal-title":"Arab J Gastroenterol"},{"key":"R6-20260204","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.","volume":"29","author":"Blad\u00e9","year":"2011","journal-title":"J Clin Oncol"},{"key":"R7-20260204","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"R8-20260204","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis.","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R9-20260204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bmt.1705395","article-title":"Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?","volume":"38","author":"Bahlis","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/0886022X.2014.884446","article-title":"Unusual manifestation of crystalline light chain tubulopathy in patient with multiple myeloma: case report and review of the literature.","volume":"36","author":"Stomp\u00f3r","year":"2014","journal-title":"Ren Fail"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"994384","DOI":"10.3389\/fcvm.2022.994384","article-title":"Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma.","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R12-20260204","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjh.16112","article-title":"A risk stratification for systemic immunoglobulin light-chain amyloidosis with renal involvement.","volume":"187","author":"Li","year":"2019","journal-title":"Br J Haematol"},{"key":"R13-20260204","first-page":"97","article-title":"A case report of AL amyloidosis complicated with multiple myeloma with dysphagia as the first symptom.","volume":"21","author":"Lin","year":"2023","journal-title":"China J Oral Maxillofac Surg"},{"key":"R14-20260204","doi-asserted-by":"crossref","first-page":"bcr2018226331","DOI":"10.1136\/bcr-2018-226331","article-title":"Dysphagia unveiling systemic immunoglobulin light-chain amyloidosis with multiple myeloma.","volume":"2018","author":"Gonzalez","year":"2018","journal-title":"BMJ Case Rep"},{"key":"R15-20260204","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","article-title":"Amyloidosis: pathogenesis and new therapeutic options.","volume":"29","author":"Merlini","year":"2011","journal-title":"J Clin Oncol"},{"key":"R16-20260204","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.leukres.2014.06.009","article-title":"Bortezomib-thalidomide-based regimens improved clinical outcomes without increasing toxicity as induction treatment for untreated multiple myeloma: a meta-analysis of phase III randomized controlled trials.","volume":"38","author":"Huang","year":"2014","journal-title":"Leuk Res"},{"key":"R17-20260204","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.3390\/curroncol30110697","article-title":"Anti-B cell maturation antigen chimeric antigen receptor T cell therapy for the treatment of AL amyloidosis and concurrent relapsed\/refractory multiple myeloma: preliminary efficacy and safety.","volume":"30","author":"Das","year":"2023","journal-title":"Curr Oncol"},{"key":"R18-20260204","doi-asserted-by":"crossref","first-page":"e003783","DOI":"10.1136\/jitc-2021-003783","article-title":"First report of CART treatment in AL amyloidosis and relapsed\/refractory multiple myeloma.","volume":"9","author":"Oliver-Caldes","year":"2021","journal-title":"J ImmunoTher Cancer"},{"key":"R19-20260204","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjh.16697","article-title":"Antibody-based immunotherapy for treatment of immunoglobulin light-chain amyloidosis.","volume":"191","author":"Parrondo","year":"2020","journal-title":"Br J Haematol"},{"key":"R20-20260204","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1080\/10428194.2021.1873320","article-title":"Measurable residual disease in multiple myeloma and light chain amyloidosis: more than meets the eye.","volume":"62","author":"Vaxman","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"R21-20260204","first-page":"1518","article-title":"AL amyloidosis and multiple myeloma: a complex scenario in which cardiac involvement remains the key prognostic factor.","volume":"13","author":"R\u00edos-Tamayo","year":"2023","journal-title":"Life (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:01:12Z","timestamp":1770213672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":21,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038968","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}